Vorinostat approved in Japan for treatment of cutaneous T-cell lymphomas: status and prospects.
about
Ritonavir and ixazomib kill bladder cancer cells by causing ubiquitinated protein accumulation.Epigenetic drugs: a novel anti-aging strategy?Highly synergistic effect of sequential treatment with epigenetic and anticancer drugs to overcome drug resistance in breast cancer cells is mediated via activation of p21 gene expression leading to G2/M cycle arrest.SIRT1 is upregulated in cutaneous T-cell lymphoma, and its inhibition induces growth arrest and apoptosis.The effects of taxanes, vorinostat and doxorubicin on growth and proliferation of Echinococcus multilocularis metacestodes assessed with magnetic resonance imaging and simultaneous positron emission tomography.
P2860
Vorinostat approved in Japan for treatment of cutaneous T-cell lymphomas: status and prospects.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Vorinostat approved in Japan f ...... mphomas: status and prospects.
@ast
Vorinostat approved in Japan f ...... mphomas: status and prospects.
@en
type
label
Vorinostat approved in Japan f ...... mphomas: status and prospects.
@ast
Vorinostat approved in Japan f ...... mphomas: status and prospects.
@en
prefLabel
Vorinostat approved in Japan f ...... mphomas: status and prospects.
@ast
Vorinostat approved in Japan f ...... mphomas: status and prospects.
@en
P2860
P356
P1476
Vorinostat approved in Japan f ...... mphomas: status and prospects.
@en
P2093
Akinori Sato
P2860
P356
10.2147/OTT.S23874
P407
P577
2012-04-27T00:00:00Z